TGA investigates influencers after diabetes drug Ozempic promoted as weight loss treatment

Regulator is looking into allegations of unlawful advertising of the drug amid huge demand

• Get our morning and afternoon news emails, free app or daily news podcast

Australia's drug regulator is investigating social media platforms and influencers after users started promoting a diabetic drug as a weight loss treatment.

The Therapeutic Goods Administration (TGA) says the circulation of videos touting Ozempic for weight loss has triggered a surge in demand and contributed to an ongoing worldwide shortage of the drug.